Contract
Exhibit 4.10
CERTIFIED translation no. 157-2022. This is a CERTIFIED translation of a document written in Spanish, which is identified with the seal of the translator. This translation was prepared by Xxxxxxx Xxxxx xxxxxxxx xxxxxx, CERTIFIED interpreter and translator pursuant to THE CERTIFICATE Of PROFESSIONAL QUALIFICATION ON CERTIFIED TRANSLATIONS AND INTERPRETationS NO. 0313 ISSUED BY “Universidad nacional de COLOMBIA” ON SEPTEMBER 14th, 2010, IN BOGOTA, COLOMBIA.
Procaps – Amendment No. 1 to Credit Agreement
Execution Version
Confidential
AMENDMENT NO. 1 TO THE CREDIT AGREEMENT
entered into by and among
Procaps S.A.
as Obligor
Laboratorios Xxxxx, X.X. de C.V., C.I. Procaps S.A., Biokemical S.A. de C.V., Pharmarketing
Xxxxxxxx X.X. de C.V. (El Salvador), Corporación
Distribuidora Internacional S.A. de C.V., CDI Nicaragua S.A.,
CDI Guatemala S.A., Pharmarketing S.A. (Guatemala), Pharmarketing S.A.
(Panamá), Pharmarketing Dominicana SRL, Pharmarketing Costa Rica S.A.,
as Co-Obligors
Inversiones Crynseen S.A.S., Inversiones Ganeden S.A.S., Inversiones Xxxxx S.A.S.,
Inversiones Jades S.A.S., Industrias Kadima S.A.S. y Pharmayect S.A.,
as Guarantors
and
Bancolombia S.A.,
Bancolombia S.A. with the name Bancolombia (Panamá Branch),
Banco Davivienda S.A.,
Banco de Sabadell S.A. Miami Branch, and
Banco de Crédito del Perú
as Creditors
and
Fiduciaria Bancolombia S.A.
as Management Agent
AMENDMENT NO. 1 TO THE CREDIT AGREEMENT
Among the undersigned, namely
(i) Procaps S.A., a business company, incorporated and existing under the laws of Colombia, with its main domicile in the city of de Barranquilla, Colombia, identified by TIN 000.000.000-5, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment, as evidenced in the certificate of existence and legal representation issued by the Chamber of Commerce de Barranquilla and in the copy of Minutes No. 787 dated November 9, 2018 of the Board of Directors, enclosed as Exhibit A hereof (the “Obligor”);
(ii) Laboratorios Xxxxx, X.X. de C.V., a business company, incorporated and existing under the laws of El Salvador, with identification number 0614-280878-003-7, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment, as evidenced in the duly granted power of attorney dated November 11, 2018 enclosed as Exhibit B hereof (“Laboratorios Xxxxx”);
(iii) C.I. Procaps S.A., a business company, incorporated and existing under the laws of Colombia, with its main domicile in the city of de Barranquilla, Colombia, identified with TIN 802.009.120 – 6, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment, as evidenced in the certificate of existence and legal representation issued by the Chamber of Commerce de Barranquilla and in the copy of Minutes No. 176 dated November 9, 2018 of the Board of Directors, enclosed as Exhibit B hereof (“C.I. Procaps”);
(iv) Biokemical S.A. de C.V., a business company, incorporated and existing under the laws of El Salvador, with identification number 0614-111194-102-0, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“Biokemical”);
(v) Pharmarketing Salvador S.A. de C.V. (El Salvador), a business company, incorporated and existing under the laws of El Salvador, with identification number 614-221-111- 102-0, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“Pharmarketing Salvador”);
(vi) Corporación Distribuidora Internacional S.A. de C.V., a business company, incorporated and existing under the laws of El Salvador, with identification number 0614-250105-101-3, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“CDI Salvador”);
(vii) CDI Nicaragua S.A., a business company, incorporated and existing under the laws of Nicaragua, identified with public mercantile registration number of the department of Managua 18,356-B5, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“CDI Nicaragua”);
(viii) CDI Guatemala S.A., a business company, incorporated and existing under the laws of Guatemala, with identification number 503628, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“CDI Guatemala”);
2
(ix) Pharmarketing S.A. (Guatemala), a business company, incorporated and existing under the laws of Guatemala, with identification number 505499, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“Pharmarketing Guatemala”);
(x) Pharmarketing S.A. (Panamá), a business company, incorporated and existing under the laws of Panamá, with identification number513994, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“Pharmarketing Panamá”);
(xi) Pharmarketing Dominicana SRL, a business company, incorporated and existing under the laws of the Dominican Republic, identified with commercial registration 57783SD, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“Pharmarketing RD”);
(xii) Pharmarketing Costa Rica S.A., a business company, incorporated and existing under the laws of Costa Rica, with identification number3-101-653826, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“Pharmarketing Costa Rica” and, together with Laboratorios Xxxxx, X.X. Procaps, Biokemical, Pharmarketing Salvador, CDI Salvador, CDI Nicaragua, CDI Guatemala, Pharmarketing Guatemala, Pharmarketing Panamá y Pharmarketing RD, the “Co-Obligors” and, jointly with the Obligor, “Joint Obligors”);
(xiii) Inversiones Crynseen S.A.S., a business company, incorporated and existing under the laws of Colombia, with its main domicile in the city of de Barranquilla, Colombia, identified with TIN 890.117.381 – 4, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment, as evidenced in the certificate of existence and legal representation issued by the Chamber of Commerce of Barranquilla enclosed hereto as Exhibit B of this Amendment (“Inversiones Crynseen”);
(xiv) Inversiones Ganeden S.A.S, a business company, incorporated and existing under the laws of Colombia, with its main domicile in the city of de Barranquilla, Colombia identified by TIN 000.000.000-4, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment, as evidenced in the certificate of existence and legal representation issued by the Chamber of Commerce of Barranquilla enclosed hereto as Exhibit B of this Amendment (“Inversiones Ganeden”);
(xv) Inversiones Xxxxx S.A.S., a business company, incorporated and existing under the laws of Colombia, with its main domicile in the city of de Barranquilla, Colombia, identified by TIN 000.000.000 -7, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment, as evidenced in the certificate of existence and legal representation issued by the Chamber of Commerce de Barranquilla enclosed hereto as Exhibit B of this Amendment (“Inversiones Xxxxx”);
3
(xvi) Inversiones Jades S.A.S., a business company, incorporated and existing under the laws of Colombia, with its main domicile in the city of Barranquilla, Colombia, identified by TIN 000.000.000-4, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment, as evidenced in the certificate of existence and legal representation issued by the Chamber of Commerce of Barranquilla enclosed hereto as Exhibit B of this Amendment (“Inversiones Jades”);
(xvii) Industrias Kadima S.A.S., a business company, incorporated and existing under the laws of Colombia, with its main domicile in the city of de Barranquilla, Colombia identified by TIN 000.000.000-4, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment, as evidenced in the certificate of existence and legal representation issued by the Chamber of Commerce de Barranquilla enclosed hereto as Exhibit B of this Amendment (“Industrias Kadima”);
(xviii) Pharmayect S.A., a business company, incorporated and existing under the laws of Colombia, with its main domicile in the city of de Barranquilla, Colombia, identified by TIN 000.000.000-4, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment, as evidenced in the certificate of existence and legal representation issued by the Chamber of Commerce de Barranquilla (“Pharmayect” and together with Inversiones Crynseen, Inversiones Ganeden, Inversiones Xxxxx, Inversiones Jades e Industrias Kadima, the “Guarantors” and, jointly with the Joint Obligors, the “Obligor Parties”);
(xix) Bancolombia S.A., banking establishment duly incorporated and existing under the laws of Colombia, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“Bancolombia”);
(xx) Bancolombia S.A. with the name Bancolombia (Panama Branch) banking institution with General License, incorporated and existing under the laws of Colombia, registered as banking institution with General License and as foreign company under the Microfilm Section (Mercantile) of the Public Registry of Panamá, file card two thousand zero thirty-four (2034) document two one eight eight two zero nine (2188209) duly empowered to act hereunder as evidenced in Public Deed number forty-five thousand three hundred sixty-two (45,362) dated December eleventh (11), two thousand fifteen (2015), corrected by Public Deed number forty-seven thousand one hundred eighty-seven (47. 187) dated December twenty-second (22), two thousand and fifteen (2015), both before the Fifth Notary Public of the Circuit of Panama, as stated in the certificate of existence and legal representation issued by the Public Registry of Panama (“Bancolombia (Panama Branch)”);
(xxi) Banco Davivienda S.A., banking establishment duly incorporated and existing under the laws of Colombia, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“Davivienda”);
(xxii) Banco de Sabadell S.A. Miami Branch, banking establishment duly incorporated and existing under the laws of Colombia, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“Sabadell”);
4
(xxiii) Banco de Crédito del Perú, banking establishment duly incorporated and existing under the laws of Colombia, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment (“BCP” and, together with Bancolombia, Bancolombia (Panama Branch), Davivienda and Sabadell, the “Creditors”); and
(xxiv) Fiduciaria Bancolombia S.A. Compañía Fiduciaria, public limited company, incorporated and existing under the laws of Colombia, with its main domicile in the city of Medellin, Colombia, identified with TIN 800.150.280-0, herein represented by the person executing this Amendment on its behalf, who acts with full and complete powers and authority to execute this Amendment, in the capacity as Management Agent and representative of the Creditors (“Management Agent”, and together with the Joint Obligors, the Guarantors, and the Creditors, the “Parties”).
The Parties, acting in the aforesaid capacity, have agreed to execute this Amendment (the “Amendment”) to the Credit Agreement entered into on November 20, 2018 among the Parties (the “Credit Agreement”), prior the following
CONSIDERATIONS
(i) On November 20, 2018, the Parties entered into the Credit Agreement for an amount of up to COP 131,848,000,000 plus the equivalent in Pesos as of the Disbursement Date of USD 21,100,000 (Tranche A) and USD 35,000,000 (Tranche B).
(ii) The Parties have agreed to modify: (a) Exhibit C - Obligations to Refinance; and (b) Exhibit 1.01 (F) Novation Terms of the Credit Agreement to adjust the amounts of certain obligations listed under the above-mentioned exhibits.
NOW THEREFORE, the Parties execute this Amendment which shall be governed by the following clauses:
CLAUSE I
DEFINITIONS AND INTERPRETATION
Section 1.1 Definitions
Capitalized terms not defined in this Amendment shall have the meaning assigned thereto under the Credit Agreement, unless such definition is modified by this Amendment or any subsequent modification, in which case it shall be understood that any subsequent modification shall prevail as the rule for interpretation of such term.
Section 1.2 Integrity
(a) Any modifications in this Amendment are an integral part of the Credit Agreement and, accordingly, all rules set forth in the Credit Agreement shall apply thereto, unless otherwise provided in the Amendment; and
(b) Except as expressly provided in this Amendment, nothing in this Amendment shall alter or modify the terms, requirements, conditions, obligations and/or rights of the Parties under the Credit Agreement. The Parties expressly represent and agree that this Amendment does not constitute a new agreement or novation of the obligations of the Parties under the Credit Agreement and the Financing Documents, but solely a variation of Exhibit C - Obligations to Refinance and Exhibit 1.01 (F) – Novation Terms of the Credit Agreement.
5
CLAUSE II
MODIFICATIONS
Section 2.1 Modification of Exhibit C of the Credit Agreement
By virtue of this Amendment, Exhibit C - Obligations to Refinance under the Credit Agreement, is substituted and replaced in its entirety by Exhibit C, enclosed to this Amendment as Exhibit C – Obligations to Refinance.
Section 2.2 Modification of Exhibit 1.01 (F) of the Credit Agreement
By virtue of this Amendment, Exhibit 1.01 (F) - Novation Terms of the Credit Agreement, is substituted and replaced in its entirety by Exhibit 1.01 (F) enclosed to this Amendment as Exhibit 1.01 (F) – Novation Terms.
CLAUSE III
VALIDITY
Section 3.1 Validity
This Amendment shall become effective as of the date of its execution by all the Parties.
Section 3.2 Governing Law and Jurisdiction
This Amendment shall be governed by, construed and enforced in accordance with Applicable Laws of Colombia. Any dispute arising from the interpretation and/or performance of this Amendment shall be subject to the jurisdiction of the judges of Colombia. The Parties expressly and irrevocably waive any other jurisdiction that, by reason of their domicile, present or future, or for any other reasons, may be applicable to them.
[signature pages below]
6
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Obligor
PROCAPS S.A.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
7
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Co-Obligor
LABORATORIOS XXXXX X.X. DE C.V.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
8
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Co-Obligor
C.I. PROCAPS S.A
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
9
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Co-Obligor
BIOKEMICAL S.A. DE C.V.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
10
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Co-Obligor
PHARMARKETING SALVADOR S.A. DE C.V. (EL SALVADOR)
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
11
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Co-Obligor
CORPORACIÓN DISTRIBUIDORA INTERNACIONAL S.A. DE C.V.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
12
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Co-Obligor
CDI NICARAGUA S.A..
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
13
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Co-Obligor
CDI GUATEMALA S.A.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
14
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Co-Obligor
PHARMARKETING S.A. (GUATEMALA)
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
15
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Co-Obligor
PHARMARKETING S.A. (PANAMA)
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
16
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Co-Obligor
PHARMARKETING DOMINICANA SRL
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
17
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Co-Obligor
PHARMARKETING COSTA RICA S.A.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
18
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Guarantor
INVERSIONES CRYNSEEN S.A.S.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
19
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Guarantor
INVERSIONES GANEDEN S.A.S.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
20
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Guarantor
INVERSIONES XXXXX S.A.S.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
21
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Guarantor
INVERSIONES JADES S.A.S.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
22
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Guarantor
INDUSTRIAS KADIMA S.A.S.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
23
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Guarantor
PHARMAYECT S.A.
[Illegible signature]
Name: Xxxxxx Xxxxxx Xxxxxxxx Xxxxx
Identification: C.C. 91.297.753
Title: Special Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
24
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Creditor
BANCOLOMBIA S.A
[Illegible signature]
Name: Xxxxx Xxxxxxxxx Xxxxxx Xxxxxx
Identification: C.C. 72.157.869
Title: Caribbean Companies Banking Vice-President
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
25
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Creditor
BANCOLOMBIA S.A WITH THE NAME BANCOLOMBIA (PANAMA BRANCH)
[Illegible signature]
Name: Xxxx Xxxxxxxx
Identification: 0-000-000
Title: General Attorney
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
26
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Creditor
BANCO DAVIVIENDA S.A.
[Illegible signature]
Name: Xxxxxxx Xxxxxx Xxxxxxxxx
Identification: C.C. 72.612.951 of Medellín
Title: Corporate Banking Vice-President
Date: December 17, 2018
Amendment No. 1 to the Credit Agreement
27
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Creditor
BANCO DE SABADELL S.A. MIAMI BEACH
[Illegible signature]
Name: Xxxxxxx Xxxxxxx
Identification:
Title: Head of Structured Finance Americas
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
28
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Creditor
BANCO DE CRÉDITO DEL PERÚ
[Illegible signature]
Name: Xxxxxxx Xxxxxxx Xxxx
Identification: CE # 259104
Title: Corporate Banking Manager
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
29
Procaps- Amendment No. 1 to the Credit Agreement
Execution Version
Confidential
IN WITNESS WHEREOF, each Party hereto has caused this Amendment to be duly executed by its respective authorized representative.
As Creditor
FIDUCIARIA BANCOLOMBIA S.A.
[Illegible signature]
Name: Xxxxxxx Xxxxxxx Xxxxxxx X.
Identification: C.C.98.541.186
Title: Alternate Legal Representative
Date: December 12, 2018
Amendment No. 1 to the Credit Agreement
******
This translation is complete, accurate, and identical to the text of the document that I have seen. This translation was made on October 31, 2022.
Xxxxxxx Xxxxx xxxxxxxx xxxxxx
Certificate of Professional Qualification on Certified Translations
and Interpretations No. 0313 issued by
“Universidad Nacional de Colombia”, on September 14th, 2010.
Email: xxxxxxxxxxxxxxx@xxxxxxxxxxxxx.xxx
Phone number: 00-0000000000
30
